PMID Title Journal Publication Year Author View in RVdb
12938393 [Assay for paracetamol by derivative spectrophotometry in compound amantadine tablets]. Guang Pu Xue Yu Guang Pu Fen Xi 2002 Zhang J;Zhang XS View More
16797866 Rescue treatment and prevention of asthma using magnesium throat lozenges: Hypothesis for a mouth-lung biologically closed electric circuit. Med Hypotheses 2006 Eby GA View More
19483370 Effects of vegetable containing gamma-aminobutyric acid on the cardiac autonomic nervous system in healthy young people. J Physiol Anthropol 2009 Okita Y;Nakamura H;Kouda K;Takahashi I;Takaoka T;Kimura M;Sugiura T View More
19713049 Hypothesis for risk of death or serious sequela from asthmatic use of magnesium throat lozenges due to 8- to 310-fold rhinovirus release increase by concentrated magnesium. Med Hypotheses 2010 Eby G View More
19906491 Zinc lozenges as cure for the common cold--a review and hypothesis. Med Hypotheses 2010 Eby GA 3rd View More
28167470 Effect of Shexiang baoxin pills on clopidogrel resistance in patients with acute coronary syndrome. Pak J Pharm Sci 2016 Zhang L;Liu N;Zhang J;Zhang H View More
2820298 Two randomized controlled trials of zinc gluconate lozenge therapy of experimentally induced rhinovirus colds. Antimicrob Agents Chemother 1987 Farr BM;Conner EM;Betts RF;Oleske J;Minnefor A;Gwaltney JM Jr View More
29464917 Head-to-head comparison of the heart rate variability between the bisoprolol transdermal patch and bisoprolol fumarate tablet. Cardiovasc Ther 2018 Sairaku A;Nakano Y;Shiode N;Suenari K;Oda N;Ono K;Kihara Y View More
3307620 Failure of effervescent zinc acetate lozenges to alter the course of upper respiratory tract infections in Australian adults. Antimicrob Agents Chemother 1987 Douglas RM;Miles HB;Moore BW;Ryan P;Pinnock CB View More
3440773 Prophylaxis and treatment of rhinovirus colds with zinc gluconate lozenges. J Antimicrob Chemother 1987 Al-Nakib W;Higgins PG;Barrow I;Batstone G;Tyrrell DA View More
35488487 A randomized, cross-over trial of metoprolol succinate formulations to evaluate PK and PD end points for therapeutic equivalence. Clin Transl Sci 2022 Mosley SA;Kim S;El Rouby N;Lingineni K;Esteban VV;Gong Y;Chen Y;Estores D;Feng K;Kim H;Kinjo M;Langaee T;Li Z;Schmidt SOF;Johnson JA;Frye RF;Fang LL;Zhao L;Binkley PF;Schmidt S;Cavallari LH View More